临床试验

Advanta VXT and Flixene PMCF Registry

NCT：NCT07161583 · RECRUITING

NCT编号NCT07161583

状态RECRUITING

开始日期2025-09-25

SponsorAtrium Medical Corporation (INDUSTRY)

First posted2025-09-08

Last updated2026-09-11

简要摘要

The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。